๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

No correlation between response and survival in patients with multiple myeloma treated with vincristine, melphalan, cyclophosphamide, and prednisone

โœ Scribed by Luca Baldini; Franca Radaelli; Ornella Chiorboli; Sandro Fumagalli; Lilla Cro; Elio E. Polli; Anna T. Maiolo; Marco Segala; Bruno M. Cesana

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
568 KB
Volume
68
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Comparison of melphalan and prednisone w
Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma : Results of Eastern Cooperative Oncology Group study E2479
โœ Martin M. Oken; David P. Harrington; Neil Abramson; Robert A. Kyle; William Knos ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 97 KB ๐Ÿ‘ 1 views

## METHODS. Four hundred seventy-nine previously untreated patients with multiple myeloma from 23 ECOG institutions were enrolled. Treatment, assigned by ran-1 The Virginia Piper Cancer Institute and the Unidomization, consisted of either 4-week cycles of MP or 5-week cycles of VBCMP.

The use of low-dose prednisone and melph
The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myeloma
โœ Cuttner, Janet ;Wasserman, L. R. ;Martz, Georg ;Sonntag, Roland W. ;Kyle, Robert ๐Ÿ“‚ Article ๐Ÿ“… 1975 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 416 KB

## Abstract A study was designed to evaluate the effectiveness of prednisone therapy in poorโ€risk patients with multiple myeloma. Patients were treated with melphalan alone or in combination with prednisone at doses of either 0.6 mg/kg or 0.3 mg/ kg. The group of patients receiving melphalan and pr

Liposome-encapsulated doxorubicin in com
Liposome-encapsulated doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac diseases or pre-treated with anthracyclines
โœ Luigi Rigacci; Silvia Mappa; Luca Nassi; Renato Alterini; Valentina Carrai; Fran ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 155 KB

## Abstract ## Background To assess the efficacy and safety of the combination of nonโ€pegylated liposomeโ€encapsulated doxorubicin (Myocetยฎ) with cyclophosphamide, vincristine, prednisone and rituximab (Rโ€COMP) in patients with aggressive nonโ€Hodgkin's Bโ€cell lymphomas. ## Methods Twentyโ€one pati